Corpus ID: 10793898

Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.

@article{Boissier2000BisphosphonatesIB,
  title={Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.},
  author={S. Boissier and M. Ferreras and O. Peyruchaud and S. Magnetto and F. Ebetino and M. Colombel and P. Delmas and J. Delaiss{\'e} and P. Cl{\'e}zardin},
  journal={Cancer research},
  year={2000},
  volume={60 11},
  pages={
          2949-54
        }
}
The molecular mechanisms by which tumor cells metastasize to bone are likely to involve invasion, cell adhesion to bone, and the release of soluble mediators from tumor cells that stimulate osteoclast-mediated bone resorption. Bisphosphonates (BPs) are powerful inhibitors of the osteoclast activity and are, therefore, used in the treatment of patients with osteolytic metastases. However, an added beneficial effect of BPs may be direct antitumor activity. We previously reported that BPs inhibit… Expand
How do bisphosphonates inhibit bone metastasis in vivo?
Bisphosphonate treatment inhibits the growth of prostate cancer cells.
Bisphosphonate Actions on Cancer
Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
  • R. Aft
  • Medicine
  • Clinical advances in hematology & oncology : H&O
  • 2011
Bisphosphonates in cancer therapy
  • J. Green
  • Medicine
  • Current opinion in oncology
  • 2002
Potential anticancer properties of bisphosphonates.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 27 REFERENCES
Reduction in new metastases in breast cancer with adjuvant clodronate treatment.
Bisphosphonates and breast carcinoma
Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL‐6 and MMP‐1 by the Tumoral Environment
  • S. Derenne, M. Amiot, +5 authors R. Bataille
  • Biology, Medicine
  • Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 1999
Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice.
...
1
2
3
...